World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as of August 2026.

World Top Biopharmaceutical Companies 2026
World Largest Biopharmaceutical Companies by Market Cap in 2026, World Top Biopharmaceutical Companies by Market Cap in 2026.

  1. AbCellera Biologics Inc.

    World Rank (Aug-2026)
    4,707
    Market Cap (Aug-2026)
    3.353 Billion USD
    World Rank (Jan-05-2024)
    6,216
    Market Cap (Jan-05-2024)
    1.724 Billion USD
    World Rank (Jul-30-2023)
    5,362
    Market Cap (Jul-30-2023)
    2.220 Billion USD
    World Rank (Dec-25-2022)
    4,125
    Market Cap (Dec-25-2022)
    2.955 Billion USD
    World Rank (Jan-07-2022)
    4,491
    Market Cap (Jan-07-2022)
    3.33 Billion USD
    Annual Revenue in USD
    288 Million USD
    Annual Net Income in USD
    118 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Canada
    Company Profile
    ABCELLERA BIOLOGICS INC. is Biotechnology sector company with headquarters is in Vancouver, Canada.
    Company Website
    ABCELLERA BIOLOGICS INC.
    Wikipedia
    Wikipedia

  2. Arcutis Biotherapeutics Inc.

    World Rank (Aug-2026)
    4,757
    Market Cap (Aug-2026)
    3.292 Billion USD
    World Rank (Jan-05-2024)
    14,287
    Market Cap (Jan-05-2024)
    0.381 Billion USD
    World Rank (Jul-30-2023)
    10,942
    Market Cap (Jul-30-2023)
    0.667 Billion USD
    World Rank (Dec-25-2022)
    9,104
    Market Cap (Dec-25-2022)
    0.871 Billion USD
    World Rank (Jan-07-2022)
    9,768
    Market Cap (Jan-07-2022)
    0.94 Billion USD
    Annual Revenue in USD
    372 Million USD
    Annual Operating Income in USD
    -12 Million USD
    Annual Net Income in USD
    -16 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Arcutis Biotherapeutics is a Pioneering Medical Dermatology company dedicated to revolutionizing the treatment of serious skin diseases. It is focused on filling the innovation gap in medical dermatology drug development by applying deep clinical, product development and commercial expertise in dermatology to develop best in class therapies against biologically validated targets. It is having  29 employees as on 2019. The headquarters is in USA.
    Company Website
    ARCUTIS BIOTHERAPEUTICS, INC.

  3. Myovant Sciences

    World Rank (Aug-2026)
    4,776
    World Rank (Jan-05-2024)
    4,776
    World Rank (Jul-30-2023)
    4,776
    Market Cap (Jul-30-2023)
    2.620 Billion USD
    World Rank (Dec-25-2022)
    4,545
    Market Cap (Dec-25-2022)
    2.608 Billion USD
    World Rank (Jan-07-2022)
    8,121
    Market Cap (Jan-07-2022)
    1.29 Billion USD
    Annual Revenue in USD
    271 Million USD
    Annual Net Income in USD
    -241 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    UK
    Company Profile

    Myovant Sciences is a biopharmaceutical company. It works for women and for men through purpose driven science, Empowering Medicines and Transformative Advocacy company. It have three clinical programs for relugolix which consisted of five international phase 3 clinical trials, two in women with heavy menstrual bleeding associated with uterine fibroids, two in women with endometriosis associated pain and one in men with advanced prostate cancer. The headquarters is in UK.

    Sumitovant Biopharma acquired Myovant Sciences for 1.7 billion USD in 2023.

    Company Website
    MYOVANT SCIENCES LTD.

  4. Aimmune Therapeutics

    World Rank (Aug-2026)
    4,918
    World Rank (Jan-05-2024)
    4,918
    World Rank (Jul-30-2023)
    4,918
    World Rank (Dec-25-2022)
    4,918
    World Rank (Jan-07-2022)
    4,918
    Annual Operating Income in USD
    -250 Million USD
    Annual Net Income in USD
    -248 Million USD
    Annual Results for Period Ending
    For year ending December-2019
    Headquarters Country
    USA
    Company Profile
    Aimmune Therapeutics is a biopharmaceutical company developing and bringing new treatments to people with potentially life-threatening food allergies. Headquarters is in USA.
    Company Website
    AIMMUNE THERAPEUTICS INC

  5. Tarsus Pharmaceuticals Inc.

    World Rank (Aug-2026)
    5,005
    Market Cap (Aug-2026)
    3.037 Billion USD
    World Rank (Jan-05-2024)
    10,892
    Market Cap (Jan-05-2024)
    0.662 Billion USD
    World Rank (Jul-30-2023)
    11,446
    Market Cap (Jul-30-2023)
    0.614 Billion USD
    World Rank (Dec-25-2022)
    14,096
    Market Cap (Dec-25-2022)
    0.387 Billion USD
    World Rank (Jan-07-2022)
    13,834
    Market Cap (Jan-07-2022)
    0.47 Billion USD
    Annual Revenue in USD
    451 Million USD
    Annual Operating Income in USD
    -71 Million USD
    Annual Net Income in USD
    -66 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    Tarsus Pharmaceuticals is a Late Clinical Stage Biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address highly prevalent conditions with limited treatment options. It is having 20 employees as on 2019. The headquarters is in USA.
    Company Website
    TARSUS PHARMACEUTICALS, INC.

  6. Disc Medicine Inc.

    World Rank (Aug-2026)
    5,015
    Market Cap (Aug-2026)
    3.027 Billion USD
    World Rank (Jan-05-2024)
    6,852
    Market Cap (Jan-05-2024)
    1.472 Billion USD
    World Rank (Jul-30-2023)
    8,317
    Market Cap (Jul-30-2023)
    1.089 Billion USD
    Annual Operating Income in USD
    -236 Million USD
    Annual Net Income in USD
    -212 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Website
    DISC MEDICINE INC.

  7. Zai Lab

    World Rank (Aug-2026)
    5,125
    Market Cap (Aug-2026)
    2.908 Billion USD
    World Rank (Jan-05-2024)
    4,807
    Market Cap (Jan-05-2024)
    2.622 Billion USD
    World Rank (Jul-30-2023)
    4,184
    Market Cap (Jul-30-2023)
    3.176 Billion USD
    World Rank (Dec-25-2022)
    4,923
    Market Cap (Dec-25-2022)
    2.320 Billion USD
    World Rank (Jan-07-2022)
    3,121
    Market Cap (Jan-07-2022)
    5.31 Billion USD
    Annual Revenue in USD
    144 Million USD
    Annual Net Income in USD
    -704 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Stock Category
    China ADRs
    Yahoo @ Nasdaq
    Company Profile

    Zai Lab is an Innovative and Research Based Commercial Stage Biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. It is having 900 employees as on 2020. The headquarters is in China.

    Company Website
    ZAI LAB LIMITED

  8. Provention Bio

    World Rank (Aug-2026)
    5,145
    World Rank (Jan-05-2024)
    5,145
    World Rank (Jul-30-2023)
    5,145
    Market Cap (Jul-30-2023)
    2.370 Billion USD
    World Rank (Dec-25-2022)
    9,337
    Market Cap (Dec-25-2022)
    0.839 Billion USD
    World Rank (Jan-07-2022)
    16,071
    Market Cap (Jan-07-2022)
    0.33 Billion USD
    Annual Revenue in USD
    13 Million USD
    Annual Operating Income in USD
    -128 Million USD
    Annual Net Income in USD
    -114 Million USD
    Annual Results for Period Ending
    For year ending December-2022
    Headquarters Country
    USA
    Company Profile

    Provention Bio is a Clinical Stage Biopharmaceutical company. The headquarters is in USA.

    Company Website
    PROVENTION BIO

  9. Nurix Therapeutics Inc.

    World Rank (Aug-2026)
    5,235
    Market Cap (Aug-2026)
    2.807 Billion USD
    World Rank (Jan-05-2024)
    12,883
    Market Cap (Jan-05-2024)
    0.478 Billion USD
    World Rank (Jul-30-2023)
    13,148
    Market Cap (Jul-30-2023)
    0.469 Billion USD
    World Rank (Dec-25-2022)
    12,559
    Market Cap (Dec-25-2022)
    0.489 Billion USD
    World Rank (Jan-07-2022)
    8,355
    Market Cap (Jan-07-2022)
    1.23 Billion USD
    Annual Revenue in USD
    84 Million USD
    Annual Operating Income in USD
    -286 Million USD
    Annual Net Income in USD
    -264 Million USD
    Annual Results for Period Ending
    For year ending November-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Nurix Therapeutics is a  Biopharmaceutical company discovers drugs that harness the bodies natural process to control protein levels and drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells as a unique therapeutic approach to treat a broad range of diseases. The company annual revenue is 17.8 million USD and 103 employees as on 2019. The headquarters is in USA.
    Company Website
    NURIX THERAPEUTICS, INC.

  10. Dice Therapeutics Inc.

    World Rank (Aug-2026)
    5,326
    World Rank (Jan-05-2024)
    5,326
    World Rank (Jul-30-2023)
    5,326
    Market Cap (Jul-30-2023)
    2.244 Billion USD
    World Rank (Dec-25-2022)
    6,517
    Market Cap (Dec-25-2022)
    1.514 Billion USD
    World Rank (Jan-07-2022)
    10,632
    Market Cap (Jan-07-2022)
    0.81 Billion USD
    Annual Operating Income in USD
    -88 Million USD
    Annual Net Income in USD
    -84 Million USD
    Annual Results for Period Ending
    For year ending December-2022
    Headquarters Country
    USA
    Company Profile

    DICE THERAPEUTICS is a Biopharmaceutical company with headquarters is in USA.

    DICE THERAPEUTICS is developing transformative medicines for autoimmune and inflammatory diseases.

    ELI LILLY COMPANY acquired DICE THERAPEUTICS, INC for 2.4 billion USD.

Share